{"url_path":"/sec/tyra/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-220645-index.html","accession_number":"0001193125-26-220645","cik":"0001863127","ticker":"TYRA","issuer_name":"Tyra Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-220645-index.html","primary_entity_key":"0001863127","primary_entity_name":"Tyra Biosciences, Inc."},"word_count":367,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\nExhibit Number\n\nExhibit Description\n\nIncorporated by Reference\n\nFiled Herewith\n\nForm\n\nDate\n\nNumber\n\n3.1\n\n[Amended and Restated Certificate of Incorporation](https://www.sec.gov/Archives/edgar/data/1863127/000095017023009181/tyra-ex3_1.htm)\n\n10-K\n\n3/22/23\n\n3.1\n\n3.2\n\n[Certificate of Amendment of Amended and Restated Certificate of Incorporation, dated May 29, 2024](https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/d807421dex31.htm)\n\n8-K\n\n5/31/24\n\n3.1\n\n3.3\n\n \n\n[Amended and Restated Bylaws, effective as of October 26, 2023](https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/d537796dex31.htm)\n\n \n\n8-K\n\n \n\n10/26/23\n\n \n\n3.1\n\n \n\n \n\n4.1\n\n[Specimen stock certificate evidencing the shares of common stock](https://www.sec.gov/Archives/edgar/data/1863127/000119312521252729/d189651dex41.htm)\n\nS-1\n\n8/20/21\n\n4.1\n\n4.2\n\n[Amended and Restated Investors’ Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders](https://www.sec.gov/Archives/edgar/data/1863127/000119312521268272/d189651dex42.htm)\n\nS-1/A\n\n9/9/21\n\n4.2\n\n4.3\n\n \n\n[Form of Pre-Funded Warrant](https://www.sec.gov/Archives/edgar/data/1863127/000119312524023367/d620082dex41.htm)\n\n \n\n8-K\n\n \n\n2/5/24\n\n \n\n4.1\n\n \n\n \n\n4.4\n\n \n\n[Form of Exchange Warrant](https://www.sec.gov/Archives/edgar/data/1863127/000119312524239650/d814860dex41.htm)\n\n \n\n8-K\n\n \n\n10/18/24\n\n \n\n4.1\n\n \n\n \n\n31.1\n\n[Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](tyra-ex31_1.htm)\n\nX\n\n31.2\n\n[Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](tyra-ex31_2.htm)\n\nX\n\n 32.1*\n\n[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](tyra-ex32_1.htm)\n\nX\n\n 32.2*\n\n[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](tyra-ex32_2.htm)\n\nX\n\n  101.INS\n\nInline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document\n\nX\n\n  101.SCH\n\nInline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents\n\nX\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nX\n\n* This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.\n\n \n\n25\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nTYRA BIOSCIENCES, INC.\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Todd Harris, Ph.D.\n\nTodd Harris, Ph.D.\n\nPresident, Chief Executive Officer, and Director\n\n \n\n (Principal Executive Officer)\n\n \n\n \n\n \n\n \n\nDate: May 13, 2026\n\nBy:\n\n/s/ Alan Fuhrman\n\nAlan Fuhrman\n\nChief Financial Officer\n\n \n\n \n\n \n\n(Principal Financial Officer)\n\n \n\n26"}